← FDA DRUG APPROVALS
FDA ANDA · ANDA078870
CETIRIZINE HYDROCHLORIDE ORAL SOLUTION
Sponsor: APOZEAL PHARMS
APPLICATION
ANDA078870
TYPE
ANDA
ORIGINAL APPROVAL
2009-04-27
LATEST ACTION
2025-07-11
ROUTE
ORAL
DOSAGE FORM
SOLUTION
MARKETING STATUS
Prescription
Products
CETIRIZINE HYDROCHLORIDEPrescription
CETIRIZINE HYDROCHLORIDE 5MG/5ML · SOLUTION · ORAL
Approval history
2025-07-11Labeling · Supplement 12 · standardAP
2023-04-19Labeling · Supplement 6 · standardAP
2016-11-08Labeling · Supplement 4 · standardAP
2009-04-27OriginalAP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.